Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mm decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
15 mm » 5 mm (Expand Search), 10 mm (Expand Search), 25 mm (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mm decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
15 mm » 5 mm (Expand Search), 10 mm (Expand Search), 25 mm (Expand Search)
-
1501
The I827K substitution destabilizes the 3D fold of E6AP<sup>C-lobe</sup> (residues 761–875).
Published 2020“…<p>(A) The assigned <sup>1</sup>H-<sup>15</sup>N-HSQC spectrum of 3.5 mM human E6AP catalytic C-lobe (residues 761–875) using the one-letter amino acid code and residue number according to the human E6AP sequence. …”
-
1502
-
1503
-
1504
-
1505
-
1506
-
1507
-
1508
-
1509
NO inhibition (L-NAME) <i>in viv</i>o results in increasing outward current in some PNs (A, B, C) and decreasing inward current in others (D, E, F).
Published 2013“…<b>B</b>. Normalized current I–V plot for control, L-NAME (15 mM), and washout (mean +/− SE; n = 4). …”
-
1510
-
1511
-
1512
-
1513
-
1514
-
1515
-
1516
-
1517
-
1518
Cullin-1/5 degradation requires Gal-lectin-mediated contact with macrophage.
Published 2021Subjects: -
1519
a-c: Bone marrow (BM) EPO receptor (EPO-R) decreases in uremic anemia rats.
Published 2018“…<p>BM EPO-R protein (depicted as percentage of actin-corrected concentration) is unchanged in 7 day-bled rats Vs controls (Fig. 4a). Contrary to that BM EPO-R protein decreases in uremic (4 weeks after 5/6 nephrectomy) rats (Fig. 4b). …”
-
1520